DIVISLAB.NS

Healthcare Drug Manufacturers - Specialty & Generic

Divi's Laboratories Limited

₹9,546.50

-3.50 -0.04% today

Price History

Not enough data

Key Stats

Market Cap

2.53T

Avg Volume

482,440

P/E (TTM)

86.62

EPS

₹110.21

52W High

₹9,740.00

52W Low

₹5,647.50

Div. Yield

0.0%

Analyst Ratings

Hold

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

63.21

P/B Ratio

15.12

P/S Ratio

22.57

EV/EBITDA

63.12

EV/Revenue

22.29

Margins

Gross Margin 61.2%

Operating Margin 36.7%

Net Margin 26.0%

EBITDA Margin 35.3%

Growth & Returns

Revenue Growth (YoY)

27.8%

Earnings Growth (YoY)

65.7%

Earnings Growth (QoQ)

65.5%

Liquidity & Leverage

Debt / Equity

0.00

Total Cash

32.33B

Total Debt

70.00M

About

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally. The company also undertakes custom synthesis contract manufacturing services of APIs and intermediates; and supplies a range of carotenoids, such as astaxanthin, beta-carotene, lycopene, canthaxanthin, apocarotenal, and vitamins used in the food, beverage, dietary supplement, pet food, and feed industries. It also exports its products. The company was formerly known as Divi's Research Center and changed its name to Divi's Laboratories Limited in 1994. Divi's Laboratories Limited was incorporated in 1990 and is based in Hyderabad, India.